Skip to main content

All Publications

Michael McDermott, Miami Neuroscience InstituteFollow

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Publication Date

2021

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Neuro-Oncology (2021) 23(11):1872-1884

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS